ReP USP - Resultado da busca

Artigo de periodico
GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia (2022)
Kiemes, Amanda; Gomes, Felipe Villela ; Cash, Diana; Uliana, Daniela L.; Simmons, Camilla; Singh, Nisha; Vernon, Anthony C.; Turkheimer, Federico; Davies, Cathy; Stone, James M.; Grace, Anthony A.; Modinos, Gemma
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: MODELOS ANIMAIS DE DOENÇAS, HIPOCAMPO, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIEMES, Amanda et al. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, v. 47, n. 3, p. 687-695, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41386-021-01213-0. Acesso em: 02 out. 2024.
APA
Kiemes, A., Gomes, F. V., Cash, D., Uliana, D. L., Simmons, C., Singh, N., et al. (2022). GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, 47( 3), 687-695. doi:10.1038/s41386-021-01213-0
NLM
Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-021-01213-0
Vancouver
Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-021-01213-0
Artigo de periodico
Nucleus reuniens inactivation reverses stress-induced hypodopaminergic state and altered hippocampal-accumbens synaptic plasticity (2022)
Uliana, Daniela L.; Gomes, Felipe Villela ; Grace, Anthony A.
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: HIPOCAMPO, NÚCLEOS TALÂMICOS, PLASTICIDADE NEURONAL, NEURÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULIANA, Daniela L. e GOMES, Felipe Villela e GRACE, Anthony A. Nucleus reuniens inactivation reverses stress-induced hypodopaminergic state and altered hippocampal-accumbens synaptic plasticity. Neuropsychopharmacology, v. 47 , n. 8, p. 1513-1522, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41386-022-01333-1. Acesso em: 02 out. 2024.
APA
Uliana, D. L., Gomes, F. V., & Grace, A. A. (2022). Nucleus reuniens inactivation reverses stress-induced hypodopaminergic state and altered hippocampal-accumbens synaptic plasticity. Neuropsychopharmacology, 47 ( 8), 1513-1522. doi:10.1038/s41386-022-01333-1
NLM
Uliana DL, Gomes FV, Grace AA. Nucleus reuniens inactivation reverses stress-induced hypodopaminergic state and altered hippocampal-accumbens synaptic plasticity [Internet]. Neuropsychopharmacology. 2022 ;47 ( 8): 1513-1522.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-022-01333-1
Vancouver
Uliana DL, Gomes FV, Grace AA. Nucleus reuniens inactivation reverses stress-induced hypodopaminergic state and altered hippocampal-accumbens synaptic plasticity [Internet]. Neuropsychopharmacology. 2022 ;47 ( 8): 1513-1522.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-022-01333-1
Trabalho de evento-resumo periodico
Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2 (2021)
Ferreira, Rafael Rinaldi; Costa, Karla Cristinne Mancini ; Santos, Isabela Pires dos; Scomparin, Davi Silveira; Scarante, Franciele Franco ; Martins Júnior, Ronaldo Bragança; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Guedes, Isabella; Dardenne, Laurent; Guimarães, Francisco Silveira ; Hallak, Jaime Eduardo Cecilio ; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza ; Arruda Neto, Eurico; Campos, Alline Cristina de
Fonte: Neuropsychopharmacology. Nome do evento: ACNP Annual Meeting. Unidades: FCFRP, FMRP, ESALQ
Assuntos: CANABINOIDES, COVID-19, VIROSES, DOENÇAS DO SISTEMA NERVOSO, CANABINOIDES, COVID-19, VIROSES, DOENÇAS DO SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rafael Rinaldi et al. Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2. Neuropsychopharmacology. London: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://www.nature.com/articles/s41386-021-01237-6#Sec289. Acesso em: 02 out. 2024. , 2021
APA
Ferreira, R. R., Costa, K. C. M., Santos, I. P. dos, Scomparin, D. S., Scarante, F. F., Martins Júnior, R. B., et al. (2021). Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2. Neuropsychopharmacology. London: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://www.nature.com/articles/s41386-021-01237-6#Sec289
NLM
Ferreira RR, Costa KCM, Santos IP dos, Scomparin DS, Scarante FF, Martins Júnior RB, Batah SS, Fabro AT, Guedes I, Dardenne L, Guimarães FS, Hallak JEC, Zuardi AW, Crippa JA de S, Arruda Neto E, Campos AC de. Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2 [Internet]. Neuropsychopharmacology. 2021 ; 46( suppl. 1): 301-302.[citado 2024 out. 02 ] Available from: https://www.nature.com/articles/s41386-021-01237-6#Sec289
Vancouver
Ferreira RR, Costa KCM, Santos IP dos, Scomparin DS, Scarante FF, Martins Júnior RB, Batah SS, Fabro AT, Guedes I, Dardenne L, Guimarães FS, Hallak JEC, Zuardi AW, Crippa JA de S, Arruda Neto E, Campos AC de. Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2 [Internet]. Neuropsychopharmacology. 2021 ; 46( suppl. 1): 301-302.[citado 2024 out. 02 ] Available from: https://www.nature.com/articles/s41386-021-01237-6#Sec289
Artigo de periodico
Stress impacts corticoamygdalar connectivity in an age-dependent manner (2021)
Uliana, Daniela L.; Gomes, Felipe Villela ; Grace, Anthony A.
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: NEURÔNIOS, CÓRTEX PRÉ-FRONTAL, ESTRESSE, CÉREBRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULIANA, Daniela L. e GOMES, Felipe Villela e GRACE, Anthony A. Stress impacts corticoamygdalar connectivity in an age-dependent manner. Neuropsychopharmacology, v. 46, n. 4, p. 731-740, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41386-020-00886-3. Acesso em: 02 out. 2024.
APA
Uliana, D. L., Gomes, F. V., & Grace, A. A. (2021). Stress impacts corticoamygdalar connectivity in an age-dependent manner. Neuropsychopharmacology, 46( 4), 731-740. doi:10.1038/s41386-020-00886-3
NLM
Uliana DL, Gomes FV, Grace AA. Stress impacts corticoamygdalar connectivity in an age-dependent manner [Internet]. Neuropsychopharmacology. 2021 ; 46( 4): 731-740.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-020-00886-3
Vancouver
Uliana DL, Gomes FV, Grace AA. Stress impacts corticoamygdalar connectivity in an age-dependent manner [Internet]. Neuropsychopharmacology. 2021 ; 46( 4): 731-740.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-020-00886-3
Artigo de periodico
Shared genetic background between children and adults with attention deficit/hyperactivity disorder (2020)
Rovira, Paula ; Demontis, Ditte ; Sánchez-Mora, Cristina ; Zayats, Tetyana ; Klein, Marieke ; Mota, Nina Roth ; Weber, Heike ; Garcia-Martínez, Iris ; Pagerols, Mireia ; Villar-Ribó, Laura ; Arribas, Lorena ; Richarte, Vanessa ; Corrales, Montserrat ; Fadeuilhe, Christian ; Bosch, Rosa ; Español-Martin, Gemma ; Almos, Peter ; Doyle, Alysa E. ; Grevet, Eugenio Horacio ; Grimm, Oliver ; Halmøy, Anne ; Martine Hoogman ; Hutz, Mara ; Jacob, Christian P.; Kittel-Schneider, Sarah ; Knappskog, Per M.; Rivero, Olga ; Salatino-Oliveira, Angelica ; Silva, Bruna Santos da ; Svirin, Evgeniy ; Lundervold, Astri J. ; Sprooten, Emma ; Strekalova, Tatyana ; Arias-Vasquez, Alejandro ; Sonuga-Barke, Edmund James J. ; Asherson, Philip ; Bau, Claiton Henrique Dotto ; Buitelaar, Jan K. ; Cormand, Bru ; Faraone, Stephen V. ; Haavik, Jan ; Johansson, Stefan E. ; Kuntsi, Jonna ; Larsson, Henrik ; Lesch, Klaus-Peter ; Reif, Andreas ; Rohde, Luis Augusto ; Casas, Miquel ; Børglum, Anders D. ; Franke, Barbara ; Ramos-Quiroga, Josep Antoni ; Artigas, Maria Soler ; Ribasés, Marta ; Rovaris, Diego Luiz
Fonte: Neuropsychopharmacology. Unidade: ICB
Assuntos: FISIOLOGIA, TRANSTORNO DO DEFICIT DE ATENÇÃO COM HIPERATIVIDADE, ATENÇÃO, GENOMAS, COMPORTAMENTO IMPULSIVO, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVIRA, Paula et al. Shared genetic background between children and adults with attention deficit/hyperactivity disorder. Neuropsychopharmacology, v. 45, p. 1617–1626, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41386-020-0664-5. Acesso em: 02 out. 2024.
APA
Rovira, P., Demontis, D., Sánchez-Mora, C., Zayats, T., Klein, M., Mota, N. R., et al. (2020). Shared genetic background between children and adults with attention deficit/hyperactivity disorder. Neuropsychopharmacology, 45, 1617–1626. doi:10.1038/s41386-020-0664-5
NLM
Rovira P, Demontis D, Sánchez-Mora C, Zayats T, Klein M, Mota NR, Weber H, Garcia-Martínez I, Pagerols M, Villar-Ribó L, Arribas L, Richarte V, Corrales M, Fadeuilhe C, Bosch R, Español-Martin G, Almos P, Doyle AE, Grevet EH, Grimm O, Halmøy A, Martine Hoogman, Hutz M, Jacob CP, Kittel-Schneider S, Knappskog PM, Rivero O, Salatino-Oliveira A, Silva BS da, Svirin E, Lundervold AJ, Sprooten E, Strekalova T, Arias-Vasquez A, Sonuga-Barke EJJ, Asherson P, Bau CHD, Buitelaar JK, Cormand B, Faraone SV, Haavik J, Johansson SE, Kuntsi J, Larsson H, Lesch K-P, Reif A, Rohde LA, Casas M, Børglum AD, Franke B, Ramos-Quiroga JA, Artigas MS, Ribasés M, Rovaris DL. Shared genetic background between children and adults with attention deficit/hyperactivity disorder [Internet]. Neuropsychopharmacology. 2020 ; 45 1617–1626.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-020-0664-5
Vancouver
Rovira P, Demontis D, Sánchez-Mora C, Zayats T, Klein M, Mota NR, Weber H, Garcia-Martínez I, Pagerols M, Villar-Ribó L, Arribas L, Richarte V, Corrales M, Fadeuilhe C, Bosch R, Español-Martin G, Almos P, Doyle AE, Grevet EH, Grimm O, Halmøy A, Martine Hoogman, Hutz M, Jacob CP, Kittel-Schneider S, Knappskog PM, Rivero O, Salatino-Oliveira A, Silva BS da, Svirin E, Lundervold AJ, Sprooten E, Strekalova T, Arias-Vasquez A, Sonuga-Barke EJJ, Asherson P, Bau CHD, Buitelaar JK, Cormand B, Faraone SV, Haavik J, Johansson SE, Kuntsi J, Larsson H, Lesch K-P, Reif A, Rohde LA, Casas M, Børglum AD, Franke B, Ramos-Quiroga JA, Artigas MS, Ribasés M, Rovaris DL. Shared genetic background between children and adults with attention deficit/hyperactivity disorder [Internet]. Neuropsychopharmacology. 2020 ; 45 1617–1626.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-020-0664-5
Artigo de periodico
Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity (2018)
Uliana, Daniela L.; Resstel, Leonardo Barbosa Moraes; Grace, Anthony A.
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: MEDO, ESQUIZOFRENIA, ROEDORES, NEUROFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ULIANA, Daniela L. e RESSTEL, Leonardo Barbosa Moraes e GRACE, Anthony A. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity. Neuropsychopharmacology, v. 43, n. 12, p. 2459-2467, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41386-018-0128-3. Acesso em: 02 out. 2024.
APA
Uliana, D. L., Resstel, L. B. M., & Grace, A. A. (2018). Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity. Neuropsychopharmacology, 43( 12), 2459-2467. doi:10.1038/s41386-018-0128-3
NLM
Uliana DL, Resstel LBM, Grace AA. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity [Internet]. Neuropsychopharmacology. 2018 ; 43( 12): 2459-2467.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-018-0128-3
Vancouver
Uliana DL, Resstel LBM, Grace AA. Fear extinction disruption in a developmental rodent model of schizophrenia correlates with an impairment in basolateral amygdala-medial prefrontal cortex plasticity [Internet]. Neuropsychopharmacology. 2018 ; 43( 12): 2459-2467.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-018-0128-3
Artigo de periodico
Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 (2018)
Lisboa, Sabrina Francesca; Niraula, Anzela; Resstel, Leonardo Barbosa Moraes; Guimarães, Francisco Silveira; Godbout, Jonathan P.; Sheridan, John F.
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: CANABINOIDES, ANSIEDADE, MEDO, NEUROFARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA, Sabrina Francesca et al. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2. Neuropsychopharmacology, v. 43, n. 9, p. 1924-1933, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41386-018-0064-2. Acesso em: 02 out. 2024.
APA
Lisboa, S. F., Niraula, A., Resstel, L. B. M., Guimarães, F. S., Godbout, J. P., & Sheridan, J. F. (2018). Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2. Neuropsychopharmacology, 43( 9), 1924-1933. doi:10.1038/s41386-018-0064-2
NLM
Lisboa SF, Niraula A, Resstel LBM, Guimarães FS, Godbout JP, Sheridan JF. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 [Internet]. Neuropsychopharmacology. 2018 ; 43( 9): 1924-1933.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-018-0064-2
Vancouver
Lisboa SF, Niraula A, Resstel LBM, Guimarães FS, Godbout JP, Sheridan JF. Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2 [Internet]. Neuropsychopharmacology. 2018 ; 43( 9): 1924-1933.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/s41386-018-0064-2
Artigo de periodico
Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial (2017)
Tavares, Diego F.; Lafer, Beny; Gattaz, Wagner
Fonte: Neuropsychopharmacology. Unidade: FM
Assuntos: TRANSTORNO BIPOLAR, DEPRESSÃO, ESTUDOS RANDOMIZADOS, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Diego F. e LAFER, Beny e GATTAZ, Wagner. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial. Neuropsychopharmacology, v. 42, n. 13, p. 2593-2601, 2017Tradução . . Disponível em: https://doi.org/10.1038/npp.2017.26. Acesso em: 02 out. 2024.
APA
Tavares, D. F., Lafer, B., & Gattaz, W. (2017). Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial. Neuropsychopharmacology, 42( 13), 2593-2601. doi:10.1038/npp.2017.26
NLM
Tavares DF, Lafer B, Gattaz W. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial [Internet]. Neuropsychopharmacology. 2017 ; 42( 13): 2593-2601.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2017.26
Vancouver
Tavares DF, Lafer B, Gattaz W. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial [Internet]. Neuropsychopharmacology. 2017 ; 42( 13): 2593-2601.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2017.26
Trabalho de evento-resumo periodico
Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy (2015)
Costa, Douglas; Batistuzzo, Marcelo; Duran, Fabio; Greenberg, Benjamin; Canteras, Miguel; Shavitt, Roseli; Gentil, Andre; Miguel, Euripedes; Lopes, Antonio; Hoext, Marcelo
Fonte: Neuropsychopharmacology. Nome do evento: Annual Meeting of the American College of Neuropsychopharmacology. Unidade: FM
Assuntos: TRANSTORNO OBSESSIVO-COMPULSIVO (FISIOPATOLOGIA), SINAIS E SINTOMAS, PREVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Douglas et al. Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy. Neuropsychopharmacology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.nature.com/npp/journal/v40/n1s/pdf/npp2015327a.pdf. Acesso em: 02 out. 2024. , 2015
APA
Costa, D., Batistuzzo, M., Duran, F., Greenberg, B., Canteras, M., Shavitt, R., et al. (2015). Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy. Neuropsychopharmacology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.nature.com/npp/journal/v40/n1s/pdf/npp2015327a.pdf
NLM
Costa D, Batistuzzo M, Duran F, Greenberg B, Canteras M, Shavitt R, Gentil A, Miguel E, Lopes A, Hoext M. Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy [Internet]. Neuropsychopharmacology. 2015 ; 40 S453-S454.[citado 2024 out. 02 ] Available from: http://www.nature.com/npp/journal/v40/n1s/pdf/npp2015327a.pdf
Vancouver
Costa D, Batistuzzo M, Duran F, Greenberg B, Canteras M, Shavitt R, Gentil A, Miguel E, Lopes A, Hoext M. Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy [Internet]. Neuropsychopharmacology. 2015 ; 40 S453-S454.[citado 2024 out. 02 ] Available from: http://www.nature.com/npp/journal/v40/n1s/pdf/npp2015327a.pdf
Trabalho de evento-resumo periodico
Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder (2014)
Hoexter, Marcelo; Diniz, Juliana; Lopes, Antonio; Batistuzzo, Marcelo; Shavitt, Roseli; Dougherty, Darin; Duran, Fabio; Bressan, Rodrigo; Busatto, Geraldo; Miguel, Euripides; Sato, João
Fonte: Neuropsychopharmacology. Nome do evento: American College of Neuropsychopharmacology (ACNP). Unidade: FM
Assuntos: TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA), BIOMARCADORES, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo et al. Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder. Neuropsychopharmacology. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 out. 2024. , 2014
APA
Hoexter, M., Diniz, J., Lopes, A., Batistuzzo, M., Shavitt, R., Dougherty, D., et al. (2014). Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder. Neuropsychopharmacology. New York: Faculdade de Medicina, Universidade de São Paulo.
NLM
Hoexter M, Diniz J, Lopes A, Batistuzzo M, Shavitt R, Dougherty D, Duran F, Bressan R, Busatto G, Miguel E, Sato J. Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder. Neuropsychopharmacology. 2014 ; 39( 51): S230-231.[citado 2024 out. 02 ]
Vancouver
Hoexter M, Diniz J, Lopes A, Batistuzzo M, Shavitt R, Dougherty D, Duran F, Bressan R, Busatto G, Miguel E, Sato J. Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder. Neuropsychopharmacology. 2014 ; 39( 51): S230-231.[citado 2024 out. 02 ]
Trabalho de evento-resumo periodico
Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage (2014)
Senço, Natasha; Huang, Yu; D'Urso, Giordano; Parra, Lucas; Bikson, Marom; Mantovani, Antonio; Shavitt, Roseli; Hoexter, Marcelo; Brunoni, Andre; Miguel, Euripides
Fonte: Neuropsychopharmacology. Nome do evento: American College of Neuropsychopharmacology (ACNP). Unidades: RUSP, FM
Assuntos: TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA), TERAPIA POR ESTIMULAÇÃO ELÉTRICA, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SENÇO, Natasha et al. Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage. Neuropsychopharmacology. New York: , Universidade de São Paulo. . Acesso em: 02 out. 2024. , 2014
APA
Senço, N., Huang, Y., D'Urso, G., Parra, L., Bikson, M., Mantovani, A., et al. (2014). Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage. Neuropsychopharmacology. New York: , Universidade de São Paulo.
NLM
Senço N, Huang Y, D'Urso G, Parra L, Bikson M, Mantovani A, Shavitt R, Hoexter M, Brunoni A, Miguel E. Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage. Neuropsychopharmacology. 2014 ; 39( 51): S559.[citado 2024 out. 02 ]
Vancouver
Senço N, Huang Y, D'Urso G, Parra L, Bikson M, Mantovani A, Shavitt R, Hoexter M, Brunoni A, Miguel E. Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage. Neuropsychopharmacology. 2014 ; 39( 51): S559.[citado 2024 out. 02 ]
Artigo de periodico
Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder (2013)
Soeiro-de-Souza, Márcio Gerhardt; Salvadore, Giacomo; Moreno, Ricardo Alberto; Otaduy, Maria Concepción Garcia; Chaim, Kalil T.; Gattaz, Wagner F.; Zarate Jr., Carlos A.; Machado-Vieira, Rodrigo
Fonte: Neuropsychopharmacology. Unidade: FM
Assuntos: TRANSTORNO BIPOLAR, POLIMORFISMO, GLUTAMATOS, CÁLCIO, DEPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOEIRO-DE-SOUZA, Márcio Gerhardt et al. Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder. Neuropsychopharmacology, v. 38, n. 3, p. 468-475, 2013Tradução . . Disponível em: https://doi.org/10.1038/npp.2012.203. Acesso em: 02 out. 2024.
APA
Soeiro-de-Souza, M. G., Salvadore, G., Moreno, R. A., Otaduy, M. C. G., Chaim, K. T., Gattaz, W. F., et al. (2013). Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder. Neuropsychopharmacology, 38( 3), 468-475. doi:10.1038/npp.2012.203
NLM
Soeiro-de-Souza MG, Salvadore G, Moreno RA, Otaduy MCG, Chaim KT, Gattaz WF, Zarate Jr. CA, Machado-Vieira R. Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder [Internet]. Neuropsychopharmacology. 2013 ; 38( 3): 468-475.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2012.203
Vancouver
Soeiro-de-Souza MG, Salvadore G, Moreno RA, Otaduy MCG, Chaim KT, Gattaz WF, Zarate Jr. CA, Machado-Vieira R. Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder [Internet]. Neuropsychopharmacology. 2013 ; 38( 3): 468-475.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2012.203
Artigo de periodico
Anti-aversive effects cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake epicrates cenchria crassus confrontation paradigm (2012)
Mariño, Andrés Uribe; Francisco, Audrey; Urbina, Maria Angélica Castiblanco; Towardowschy, André; Rohner, Carlos José Salgado; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Zuardi, Antonio Waldo; Coimbra, Norberto Cysne
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: CANNABIS, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIÑO, Andrés Uribe et al. Anti-aversive effects cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake epicrates cenchria crassus confrontation paradigm. Neuropsychopharmacology, v. 37, n. 2, p. 412-421, 2012Tradução . . Acesso em: 02 out. 2024.
APA
Mariño, A. U., Francisco, A., Urbina, M. A. C., Towardowschy, A., Rohner, C. J. S., Crippa, J. A. de S., et al. (2012). Anti-aversive effects cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake epicrates cenchria crassus confrontation paradigm. Neuropsychopharmacology, 37( 2), 412-421.
NLM
Mariño AU, Francisco A, Urbina MAC, Towardowschy A, Rohner CJS, Crippa JA de S, Hallak JEC, Zuardi AW, Coimbra NC. Anti-aversive effects cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake epicrates cenchria crassus confrontation paradigm. Neuropsychopharmacology. 2012 ; 37( 2): 412-421.[citado 2024 out. 02 ]
Vancouver
Mariño AU, Francisco A, Urbina MAC, Towardowschy A, Rohner CJS, Crippa JA de S, Hallak JEC, Zuardi AW, Coimbra NC. Anti-aversive effects cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake epicrates cenchria crassus confrontation paradigm. Neuropsychopharmacology. 2012 ; 37( 2): 412-421.[citado 2024 out. 02 ]
Artigo de periodico
Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial (2012)
Hoexter, Marcelo Queiroz; Duran, Fábio Luis de Souza; D'Alcante, Carina Chaubet; Dougherty, Darin Dean; Shavitt, Antonio Carlos Lopes; Diniz, Juliana Belo; Deckersbach, Thilo; Batistuzzo, Marcelo Camargo; Bressan, Rodrigo Affonseca; Miguel, Euripedes Constantino; Busatto Filho, Geraldo
Fonte: Neuropsychopharmacology. Unidade: FM
Assuntos: TRANSTORNO OBSESSIVO-COMPULSIVO, TERAPIA COGNITIVA, TERAPIA COMPORTAMENTAL, NEUROTRANSMISSORES (ANÁLISE), IMAGEM POR RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo Queiroz et al. Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial. Neuropsychopharmacology, v. 37, n. 3, p. 734-745, 2012Tradução . . Disponível em: https://doi.org/10.1038/npp.2011.250. Acesso em: 02 out. 2024.
APA
Hoexter, M. Q., Duran, F. L. de S., D'Alcante, C. C., Dougherty, D. D., Shavitt, A. C. L., Diniz, J. B., et al. (2012). Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial. Neuropsychopharmacology, 37( 3), 734-745. doi:10.1038/npp.2011.250
NLM
Hoexter MQ, Duran FL de S, D'Alcante CC, Dougherty DD, Shavitt ACL, Diniz JB, Deckersbach T, Batistuzzo MC, Bressan RA, Miguel EC, Busatto Filho G. Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial [Internet]. Neuropsychopharmacology. 2012 ; 37( 3): 734-745.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2011.250
Vancouver
Hoexter MQ, Duran FL de S, D'Alcante CC, Dougherty DD, Shavitt ACL, Diniz JB, Deckersbach T, Batistuzzo MC, Bressan RA, Miguel EC, Busatto Filho G. Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial [Internet]. Neuropsychopharmacology. 2012 ; 37( 3): 734-745.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2011.250
Artigo de periodico
Opposing roles fo cannabinoid receptor type-I ('CB IND.1') and transient receptor potential vanillooid type-I channel (TRPVI) on the modulation of panic-like responses in rats (2012)
Casarotto, Plínio Cabrera; Terzian, Ana Luisa Bernardes; Aguiar, Daniele Cristina; Zangrossi Junior, Helio; Guimarães, Francisco Silveira; Wotjak, Carsten T.; Moreira, Fabrício de Araújo
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: CANNABIS, FARMACOLOGIA, ANSIEDADE, PÂNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASAROTTO, Plínio Cabrera et al. Opposing roles fo cannabinoid receptor type-I ('CB IND.1') and transient receptor potential vanillooid type-I channel (TRPVI) on the modulation of panic-like responses in rats. Neuropsychopharmacology, v. 37, n. 2, p. 478-486, 2012Tradução . . Acesso em: 02 out. 2024.
APA
Casarotto, P. C., Terzian, A. L. B., Aguiar, D. C., Zangrossi Junior, H., Guimarães, F. S., Wotjak, C. T., & Moreira, F. de A. (2012). Opposing roles fo cannabinoid receptor type-I ('CB IND.1') and transient receptor potential vanillooid type-I channel (TRPVI) on the modulation of panic-like responses in rats. Neuropsychopharmacology, 37( 2), 478-486.
NLM
Casarotto PC, Terzian ALB, Aguiar DC, Zangrossi Junior H, Guimarães FS, Wotjak CT, Moreira F de A. Opposing roles fo cannabinoid receptor type-I ('CB IND.1') and transient receptor potential vanillooid type-I channel (TRPVI) on the modulation of panic-like responses in rats. Neuropsychopharmacology. 2012 ;37( 2): 478-486.[citado 2024 out. 02 ]
Vancouver
Casarotto PC, Terzian ALB, Aguiar DC, Zangrossi Junior H, Guimarães FS, Wotjak CT, Moreira F de A. Opposing roles fo cannabinoid receptor type-I ('CB IND.1') and transient receptor potential vanillooid type-I channel (TRPVI) on the modulation of panic-like responses in rats. Neuropsychopharmacology. 2012 ;37( 2): 478-486.[citado 2024 out. 02 ]
Artigo de periodico
On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment (2012)
Stern, Cristina A. J.; Gazarini, Lucas; Takahashi, Reinaldo N.; Guimarães, Francisco Silveira; Bertoglio, Leandro José
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: CANNABIS (COMPONENTES), MEDO (EFEITOS DE DROGAS), MEMÓRIA (FISIOLOGIA), MEDICINA BASEADA EM EVIDÊNCIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STERN, Cristina A. J. et al. On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology, v. 37, n. 9, p. 2132-2142, 2012Tradução . . Disponível em: https://doi.org/10.1038/npp.2012.63. Acesso em: 02 out. 2024.
APA
Stern, C. A. J., Gazarini, L., Takahashi, R. N., Guimarães, F. S., & Bertoglio, L. J. (2012). On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology, 37( 9), 2132-2142. doi:10.1038/npp.2012.63
NLM
Stern CAJ, Gazarini L, Takahashi RN, Guimarães FS, Bertoglio LJ. On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment [Internet]. Neuropsychopharmacology. 2012 ; 37( 9): 2132-2142.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2012.63
Vancouver
Stern CAJ, Gazarini L, Takahashi RN, Guimarães FS, Bertoglio LJ. On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment [Internet]. Neuropsychopharmacology. 2012 ; 37( 9): 2132-2142.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2012.63
Artigo de periodico
Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure (2011)
Pavesi, Eloisa; Canteras, Newton Sabino ; Carobrez, Antônio P.
Fonte: Neuropsychopharmacology. Unidade: ICB
Assunto: ANATOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVESI, Eloisa e CANTERAS, Newton Sabino e CAROBREZ, Antônio P. Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure. Neuropsychopharmacology, v. 36, n. 5, p. 926-939, 2011Tradução . . Disponível em: https://doi.org/10.1038/npp.2010.231. Acesso em: 02 out. 2024.
APA
Pavesi, E., Canteras, N. S., & Carobrez, A. P. (2011). Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure. Neuropsychopharmacology, 36( 5), 926-939. doi:10.1038/npp.2010.231
NLM
Pavesi E, Canteras NS, Carobrez AP. Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure [Internet]. Neuropsychopharmacology. 2011 ; 36( 5): 926-939.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2010.231
Vancouver
Pavesi E, Canteras NS, Carobrez AP. Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure [Internet]. Neuropsychopharmacology. 2011 ; 36( 5): 926-939.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2010.231
Artigo de periodico
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: a fMRI study (2011)
Winton-Brown, Toby T.; Allen, Paul; Bhattacharrya, Sagnik; Borgwardt, Stefan J.; Fusar-Poli, Paolo; Crippa, José Alexandre de Souza; Seal, Marc L.; Martin-Santos, Rocio; Ffytche, Dominic; Zuardi, Antonio Waldo; Atakan, Zerrin; McGuire, Philip K.
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: CANNABIS (COMPONENTES;EFEITOS), RESSONÂNCIA MAGNÉTICA, PSICOPATOLOGIA (DIAGNÓSTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WINTON-BROWN, Toby T. et al. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: a fMRI study. Neuropsychopharmacology, v. 36, n. 7, p. 1340-1348, 2011Tradução . . Disponível em: https://doi.org/10.1038/npp.2011.17. Acesso em: 02 out. 2024.
APA
Winton-Brown, T. T., Allen, P., Bhattacharrya, S., Borgwardt, S. J., Fusar-Poli, P., Crippa, J. A. de S., et al. (2011). Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: a fMRI study. Neuropsychopharmacology, 36( 7), 1340-1348. doi:10.1038/npp.2011.17
NLM
Winton-Brown TT, Allen P, Bhattacharrya S, Borgwardt SJ, Fusar-Poli P, Crippa JA de S, Seal ML, Martin-Santos R, Ffytche D, Zuardi AW, Atakan Z, McGuire PK. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: a fMRI study [Internet]. Neuropsychopharmacology. 2011 ; 36( 7): 1340-1348.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2011.17
Vancouver
Winton-Brown TT, Allen P, Bhattacharrya S, Borgwardt SJ, Fusar-Poli P, Crippa JA de S, Seal ML, Martin-Santos R, Ffytche D, Zuardi AW, Atakan Z, McGuire PK. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: a fMRI study [Internet]. Neuropsychopharmacology. 2011 ; 36( 7): 1340-1348.[citado 2024 out. 02 ] Available from: https://doi.org/10.1038/npp.2011.17
Artigo de periodico
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Naïve social phobia patients (2011)
Bergamaschi, Mateus M.; Queiroz, Regina Helena Costa; Chagas, Marcos Hortes Nisihara; Oliveira, Danielle Chaves Gomes de; De Martinis, Bruno Spinosa; Kapczinski, Flávio; Quevedo, João; Roesler, Rafael; Schröder, Nadja; Nardi, Antonio E.; Martín-Santos, Rocio; Hallak, Jaime Eduardo Cecílio; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza
Fonte: Neuropsychopharmacology. Unidades: FMRP, FFCLRP, FCFRP
Assuntos: CANNABIS (EFEITOS), ANSIOLÍTICOS, FOBIA SOCIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERGAMASCHI, Mateus M. et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Naïve social phobia patients. Neuropsychopharmacology, v. 36, n. 6, p. 1219-1226, 2011Tradução . . Acesso em: 02 out. 2024.
APA
Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., Oliveira, D. C. G. de, De Martinis, B. S., Kapczinski, F., et al. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Naïve social phobia patients. Neuropsychopharmacology, 36( 6), 1219-1226.
NLM
Bergamaschi MM, Queiroz RHC, Chagas MHN, Oliveira DCG de, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Naïve social phobia patients. Neuropsychopharmacology. 2011 ; 36( 6): 1219-1226.[citado 2024 out. 02 ]
Vancouver
Bergamaschi MM, Queiroz RHC, Chagas MHN, Oliveira DCG de, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Naïve social phobia patients. Neuropsychopharmacology. 2011 ; 36( 6): 1219-1226.[citado 2024 out. 02 ]
Artigo de periodico
Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology (2010)
Bhattacharyya, Sagnik; Morrison, Paul D.; Fusar-Poli, Paolo; Martin-Santos, Rocio; Borgwardt, Stefan; Wionton-Brown, Toby; Nosarti, Chiara; Carroll, Collin M. O'; Seal, Marc; Allen, Paul; Mehta, Mitul A.; Stone, James M; Tunstall, Nigel; Giampietro, Vincent; Kapur, Shitij; Murray, Robin M; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza; Atakan, Zerrin; McGuire, Philip K
Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: TRANSTORNOS PSICÓTICOS, ANSIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHATTACHARYYA, Sagnik et al. Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology, v. 35, n. 3, p. 764-774, 2010Tradução . . Acesso em: 02 out. 2024.
APA
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Wionton-Brown, T., et al. (2010). Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology, 35( 3), 764-774.
NLM
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Wionton-Brown T, Nosarti C, Carroll CMO', Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA de S, Atakan Z, McGuire PK. Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010 ; 35( 3): 764-774.[citado 2024 out. 02 ]
Vancouver
Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Wionton-Brown T, Nosarti C, Carroll CMO', Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA de S, Atakan Z, McGuire PK. Opposite effects of 'delta'-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010 ; 35( 3): 764-774.[citado 2024 out. 02 ]

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos